BRPI0915866A2 - composições farmacêuticas baseadas em antagonistas receptores b2 de cinina e corticosteroides, e seu uso - Google Patents

composições farmacêuticas baseadas em antagonistas receptores b2 de cinina e corticosteroides, e seu uso

Info

Publication number
BRPI0915866A2
BRPI0915866A2 BRPI0915866A BRPI0915866A BRPI0915866A2 BR PI0915866 A2 BRPI0915866 A2 BR PI0915866A2 BR PI0915866 A BRPI0915866 A BR PI0915866A BR PI0915866 A BRPI0915866 A BR PI0915866A BR PI0915866 A2 BRPI0915866 A2 BR PI0915866A2
Authority
BR
Brazil
Prior art keywords
kinin
corticosteroids
pharmaceutical compositions
receptor antagonists
compositions based
Prior art date
Application number
BRPI0915866A
Other languages
English (en)
Inventor
Carlo Alberto Maggi
Sandro Giuliani
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of BRPI0915866A2 publication Critical patent/BRPI0915866A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0915866A 2008-07-11 2009-07-03 composições farmacêuticas baseadas em antagonistas receptores b2 de cinina e corticosteroides, e seu uso BRPI0915866A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2008A001264A IT1391236B1 (it) 2008-07-11 2008-07-11 Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
PCT/EP2009/004847 WO2010003601A1 (en) 2008-07-11 2009-07-03 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use

Publications (1)

Publication Number Publication Date
BRPI0915866A2 true BRPI0915866A2 (pt) 2015-11-03

Family

ID=40466843

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915866A BRPI0915866A2 (pt) 2008-07-11 2009-07-03 composições farmacêuticas baseadas em antagonistas receptores b2 de cinina e corticosteroides, e seu uso

Country Status (36)

Country Link
US (1) US8476276B2 (pt)
EP (1) EP2303268B1 (pt)
JP (1) JP5791501B2 (pt)
KR (1) KR101656324B1 (pt)
CN (1) CN102088975B (pt)
AP (1) AP2803A (pt)
AR (1) AR072734A1 (pt)
AU (1) AU2009267416B2 (pt)
BR (1) BRPI0915866A2 (pt)
CA (1) CA2730420A1 (pt)
CO (1) CO6341556A2 (pt)
CR (1) CR20110021A (pt)
CY (1) CY1112900T1 (pt)
DK (1) DK2303268T3 (pt)
EA (1) EA019903B1 (pt)
EC (1) ECSP11010752A (pt)
ES (1) ES2389872T3 (pt)
GE (1) GEP20135792B (pt)
HK (1) HK1158547A1 (pt)
HN (1) HN2011000089A (pt)
HR (1) HRP20120678T1 (pt)
IL (1) IL210554A0 (pt)
IT (1) IT1391236B1 (pt)
MA (1) MA32542B1 (pt)
MX (1) MX2011000350A (pt)
MY (1) MY150477A (pt)
NI (1) NI201100014A (pt)
NZ (1) NZ590427A (pt)
PL (1) PL2303268T3 (pt)
PT (1) PT2303268E (pt)
RS (1) RS52418B (pt)
SI (1) SI2303268T1 (pt)
TW (1) TWI499419B (pt)
UA (1) UA100060C2 (pt)
WO (1) WO2010003601A1 (pt)
ZA (1) ZA201100287B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
MX2015012650A (es) * 2013-03-14 2016-06-21 Shire Human Genetic Therapies Metodos para el tratamiento de angioedema mediado receptores debradicinina b2.
CN104072585A (zh) * 2014-07-21 2014-10-01 成都圣诺生物科技股份有限公司 一种合成艾替班特的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000696A1 (en) * 2001-06-26 2003-01-03 Metaphore Pharmaceuticals, Inc. COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
DE10304994A1 (de) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
EP1894559A1 (en) * 2006-09-01 2008-03-05 PARI Pharma GmbH Means to solubilise steroids for inhalation

Also Published As

Publication number Publication date
KR20110044970A (ko) 2011-05-03
EP2303268B1 (en) 2012-06-20
HRP20120678T1 (hr) 2012-09-30
HK1158547A1 (en) 2012-07-20
CR20110021A (es) 2011-07-11
MY150477A (en) 2014-01-30
ECSP11010752A (es) 2011-04-29
EA019903B1 (ru) 2014-07-30
UA100060C2 (uk) 2012-11-12
AR072734A1 (es) 2010-09-15
WO2010003601A1 (en) 2010-01-14
CA2730420A1 (en) 2010-01-14
AP2011005572A0 (en) 2011-02-28
IT1391236B1 (it) 2011-12-01
NZ590427A (en) 2012-09-28
CN102088975B (zh) 2013-08-21
NI201100014A (es) 2011-09-13
AU2009267416B2 (en) 2013-09-12
US20110112011A1 (en) 2011-05-12
RS52418B (en) 2013-02-28
JP5791501B2 (ja) 2015-10-07
EA201100013A1 (ru) 2011-08-30
TW201006471A (en) 2010-02-16
TWI499419B (zh) 2015-09-11
MX2011000350A (es) 2011-02-22
CO6341556A2 (es) 2011-11-21
ITMI20081264A1 (it) 2010-01-12
IL210554A0 (en) 2011-03-31
PL2303268T3 (pl) 2012-11-30
EP2303268A1 (en) 2011-04-06
KR101656324B1 (ko) 2016-09-09
AU2009267416A1 (en) 2010-01-14
HN2011000089A (es) 2013-01-28
GEP20135792B (en) 2013-03-25
JP2011527296A (ja) 2011-10-27
MA32542B1 (fr) 2011-08-01
AP2803A (en) 2013-11-30
US8476276B2 (en) 2013-07-02
SI2303268T1 (sl) 2012-10-30
ZA201100287B (en) 2012-03-28
PT2303268E (pt) 2012-09-24
ES2389872T3 (es) 2012-11-02
CY1112900T1 (el) 2016-04-13
DK2303268T3 (da) 2012-07-23
CN102088975A (zh) 2011-06-08
WO2010003601A8 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
BRPI0911563A2 (pt) uso de antagonista da progesterona
DK2081951T3 (da) Progesteron-receptorantagonister
SMT201500120B (it) Agenti di legame di notch e antagonisti di notch emetodi per il loro uso
BR112012025101A2 (pt) compostos antagonistas seletivos de receptor nk-3, composição farmacêutica e métodos para uso em distúrbios mediados por receptores nk-3
BRPI1008060A2 (pt) Agonistas e antagonistas do receptor s1p5, e métodos de uso do mesmo.
BRPI0813580A2 (pt) Antagonistas de receptor 1 de hormônio de concentração de melanina não básicos e métodos
DK2094709T3 (da) Thiazol-pyrazolopyrimidiner som CRF1-receptorantagonister
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
DK2049478T3 (da) Substituerede N-phenylmethyl-5-oxoprolin-2-amider som P2X7-receptorantagonister og fremgangsmåder til anvendelse deraf
ATE505467T1 (de) 2-aza-bicycloä3.1.0ühexanderivate als orexin- rezeptorantagonisten
BRPI0923500A2 (pt) uso e composição farmacêutica compreendendo agonista ou modulador do receptor s1p, e kit.
BRPI1010621A2 (pt) derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso
BRPI0820805A2 (pt) Antagonista do receptor de mineralocorticóides derivados da 6h-di-benzo[b,e]oxepina
ATE516853T1 (de) Zyklische peptid-cxcr4-antagonisten
BRPI0910118A2 (pt) antagonistas de receptores do glucagon
BRPI0809931A2 (pt) Antagonistas do receptor do hormônio liberador de gonadotrofina e métodos relacionados com o mesmo
BRPI0915552A2 (pt) derivados de ciclosporina, seu uso e sua composição farmacêutica
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
DK2401270T3 (da) Pyrazolderivater anvendt som CCR4-receptorantagonister.
BRPI0907053A2 (pt) Poliisobutenoamina, composição combustível, e, uso de poliisobutenoaminas
BRPI0817835A2 (pt) Antagonistas cgrp
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0811444A2 (pt) Derivados de azetidina e seu uso como antagonistas da prostaglandina e2.
ATE534628T1 (de) Urotensin ii-rezeptorantagonisten

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]